Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CANCER,NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002623
What this trial is testing

Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 640
Testing effectiveness (Phase 2)Study completedNCT00826449
What this trial is testing

Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT02838238
What this trial is testing

X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 300
Early research (Phase 1)Study completedNCT05045638
What this trial is testing

Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants

Who this might be right for
Healthy Participants
Amgen 13
Not applicableStudy completedNCT02758158
What this trial is testing

Tri-modal Imaging Instrument for Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsThyroid CancerThyroid Nodule
University Health Network, Toronto 9
Not applicableEnded earlyNCT00942058
What this trial is testing

Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Kidney CancerMetastatic Renal Cell Carcinoma
Centre Hospitalier Universitaire de Saint Etienne 16
Not applicableStudy completedNCT01597258
What this trial is testing

Safety And Efficacy Of Crizotinib (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 2,029
Large-scale testing (Phase 3)UnknownNCT03779035
What this trial is testing

Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection

Who this might be right for
CholangiocarcinomaGall Bladder Carcinoma
Tianjin Medical University Cancer Institute and Hospital 460
Testing effectiveness (Phase 2)Study completedNCT00055835
What this trial is testing

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Who this might be right for
Bladder CancerUrethral Cancer
SWOG Cancer Research Network 7
Not applicableStudy completedNCT05380908
What this trial is testing

Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small-cell Lung Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 90
Early research (Phase 1)Study completedNCT04257617
What this trial is testing

A Trial of ZL-1201 in Subjects With Advanced Cancer

Who this might be right for
Advanced Cancer
Zai Lab (Shanghai) Co., Ltd. 37
Testing effectiveness (Phase 2)Study completedNCT00190840
What this trial is testing

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company 186
Large-scale testing (Phase 3)Looking for participantsNCT06200168
What this trial is testing

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
ElectroacupunctureOlanzapine-contained Four-drug AntiemeticNausea and Vomiting
Jiuda Zhao 370
Early research (Phase 1)Looking for participantsNCT06696768
What this trial is testing

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8+1 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT05896150
What this trial is testing

Intercostal Cryoanalgesia for Acute Pain After VATS Lung Resection

Who this might be right for
Thoracic SurgeryVideo-AssistedCryotherapy Effect+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 80
Testing effectiveness (Phase 2)Ended earlyNCT01116791
What this trial is testing

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisGastrointestinal Cancer
Baki Topal 34
Not applicableWithdrawnNCT00796874
What this trial is testing

Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Post-approval studies (Phase 4)Not Yet RecruitingNCT07467174
What this trial is testing

RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy

Who this might be right for
Gastric Cancer
Yonsei University 538
Large-scale testing (Phase 3)Looking for participantsNCT07213674
What this trial is testing

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 750
Testing effectiveness (Phase 2)UnknownNCT02069418
What this trial is testing

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient

Who this might be right for
Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer RecurrentNo EGFR Activating Mutation
University Hospital, Angers 80
Next Page